Table 3 Primary Outcome measure results
MCP arm | No MCP arm | Unadjusted analysis no MCP versus MCP | Adjusted analysis ano MCP versus MCP | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | Mean | SD | N | Mean | SD | Mean difference | 95% CI | p-value | Mean difference | 95% CI | p-value | |
SGRQ -Total score | 186 | 63.88 | 19.05 | 186 | 63.52 | 19.68 | −0.36 | −4.31,3.59 | 0.8573 | 0.51 | −2.67,3.69 | 0.753 |
Effect size | −0.02 | −0.22,0.19 | 0.03 | −0.14,0.19 | ||||||||
SGRQ -Symptom score | 186 | 68.38 | 23.13 | 186 | 68.40 | 23.01 | 0.02 | −4.68,4.73 | 0.9925 | 0.87 | −3.50,5.25 | 0.695 |
Effect size | 0.00 | −0.20,0.21 | 0.04 | −0.15,0.23 | ||||||||
SGRQ -Activity score | 188 | 82.49 | 18.81 | 187 | 80.91 | 19.74 | −1.58 | −5.50,2.34 | 0.4279 | −0.36 | −3.76,3.04 | 0.836 |
Effect size | −0.08 | −0.29,0.12 | −0.02 | −0.20,0.16 | ||||||||
SGRQ -Impact score | 188 | 51.53 | 22.58 | 187 | 51.60 | 22.50 | 0.07 | −4.51,4.65 | 0.9752 | 0.43 | −3.29,4.14 | 0.822 |
Effect size | 0.00 | −0.20,0.2 | 0.02 | −0.15,0.18 | ||||||||